E-LIB Suche - Ergebnisse für: von Mehren, M.

1

62P Updated overall survival and safety with ripretinib vs ..:

Blay, J-Y. ; Jones, R.L. ; Gelderblom, H....
ESMO Open. 9 (2024) - p. 102452 , 2024

Link: https://doi.org/10.1016/..

2

Synovial sarcoma: characteristics, challenges, and evolving..:

Blay, J.-Y. ; von Mehren, M. ; Jones, R.L....
ESMO Open. 8 (2023) 5 - p. 101618 , 2023

Link: https://doi.org/10.1016/..

3

P61 Health State Utility Values and Quality of Life in Pati..:

Jones, RL ; Blay, JY ; Chi, P...
Value in Health. 25 (2022) 12 - p. S14-S15 , 2022

Link: https://doi.org/10.1016/..

4

Level of evidence used in recommendations by the National C..:

Kurzrock, R. ; Gurski, L.A. ; Carlson, R.W....
Annals of Oncology. 30 (2019) 10 - p. 1647-1652 , 2019

Link: https://doi.org/10.1093/..

5

Preliminary safety and activity in a first-in-human phase 1..:

Heinrich, M. ; Jones, R. ; Schoffski, P....
European Journal of Cancer. 69 (2016) - p. S4 , 2016

Link: https://doi.org/10.1016/..

6

1321 Efficacy and safety of trabectedin (T) or dacarbazine ..:

Von Mehren, M. ; Demetri, G.D. ; Schuetze, S.M....
European Journal of Cancer. 51 (2015) - p. S194 , 2015

Link: https://doi.org/10.1016/..

7

3403 Final overall survival (OS) analysis of the randomized..:

Patel, S. ; Mehren, M. Von ; Reed, D....
European Journal of Cancer. 51 (2015) - p. S689 , 2015

Link: https://doi.org/10.1016/..

8

3436 Efficacy and safety of trabectedin (T) or dacarbazine ..:

Demetri, G. ; Patel, S.R. ; Thomas, S....
European Journal of Cancer. 51 (2015) - p. S700 , 2015

Link: https://doi.org/10.1016/..

9

Imatinib-Resistant GIST Metastases: Predicting Outcomes of ..:

Chen, K.T. ; Farma, J. ; Von Mehren, M..
Journal of Surgical Research. 172 (2012) 2 - p. 194 , 2012

Link: https://doi.org/10.1016/..

10

1138 POSTER Neutropenia as a Biomarker of Sunitinib Efficac..:

Donskov, F. ; von Mehren, M. ; Cams, A....
European Journal of Cancer. 47 (2011) - p. S135 , 2011

Link: https://doi.org/10.1016/..

11

Evaluation of nilotinib in advanced GIST previously treated..:

Cauchi, C. ; Somaiah, N. ; Engstrom, P. F....
Cancer Chemotherapy and Pharmacology. 69 (2011) 4 - p. 977-982 , 2011

Link: https://doi.org/10.1007/..

12

9402 Efficacy and safety of trabectedin in soft tissue sarc..:

Demetri, G. ; Blay, J.Y. ; Yovine, A....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 590-591 , 2009

Link: https://doi.org/10.1016/..

13

1227 A phase 1, dose-escalation study of BIIB022 (anti-IGF-..:

von Mehren, M. ; Britten, C. ; Piesolor, P....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 128 , 2009

Link: https://doi.org/10.1016/..

14

281 POSTER Phase I and pharmacokinetic study of MLN8054, a ..:

Dees, E. ; Infante, J.R. ; Cohen, R.B....
European Journal of Cancer Supplements. 6 (2008) 12 - p. 91 , 2008

Link: https://doi.org/10.1016/..

15

7517 POSTER Clinical tolerability of trabectedin administer..:

Chawla, S. ; Casali, P.G. ; von Mehren, M....
European Journal of Cancer Supplements. 5 (2007) 4 - p. 407 , 2007

Link: https://doi.org/10.1016/..